A detailed history of Black Rock Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Black Rock Inc. holds 2,178,458 shares of RDY stock, worth $156 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,178,458
Previous 3,001,420 27.42%
Holding current value
$156 Million
Previous $209 Million 23.49%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$67.36 - $77.59 $55.4 Million - $63.9 Million
-822,962 Reduced 27.42%
2,178,458 $160 Million
Q4 2023

Feb 13, 2024

BUY
$64.27 - $69.9 $33.2 Million - $36.2 Million
517,270 Added 20.82%
3,001,420 $209 Million
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $32.5 Million - $38.2 Million
524,524 Added 26.77%
2,484,150 $166 Million
Q2 2023

Aug 11, 2023

SELL
$53.34 - $63.11 $18.3 Million - $21.7 Million
-343,437 Reduced 14.91%
1,959,626 $124 Million
Q1 2023

May 12, 2023

BUY
$51.63 - $56.93 $23.9 Million - $26.3 Million
462,799 Added 25.15%
2,303,063 $131 Million
Q4 2022

Feb 13, 2023

BUY
$51.15 - $57.45 $7.44 Million - $8.35 Million
145,387 Added 8.58%
1,840,264 $95.2 Million
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $4.15 Million - $4.77 Million
83,146 Added 5.16%
1,694,877 $88.7 Million
Q2 2022

Aug 12, 2022

BUY
$49.62 - $58.13 $1.38 Million - $1.62 Million
27,840 Added 1.76%
1,611,731 $89.3 Million
Q1 2022

May 12, 2022

BUY
$48.27 - $65.25 $1.46 Million - $1.98 Million
30,341 Added 1.95%
1,583,891 $88.3 Million
Q4 2021

Feb 10, 2022

BUY
$59.5 - $67.25 $11.3 Million - $12.7 Million
189,155 Added 13.86%
1,553,550 $102 Million
Q3 2021

Nov 09, 2021

BUY
$60.19 - $75.29 $1.5 Million - $1.88 Million
24,935 Added 1.86%
1,364,395 $88.9 Million
Q2 2021

Aug 11, 2021

BUY
$62.12 - $74.2 $83.2 Million - $99.4 Million
1,339,460 New
1,339,460 $98.5 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $11.9B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.